The Importance of Timeliness in Outbreak Response: Introducing the WHO’s Early Action Review

By Danélia Botes

September 5, 2023

The recent outbreaks of epidemic and pandemic-prone diseases have underscored the importance of timely and effective systems for outbreak detection, notification, and response. Early detection and response are crucial in preventing the escalation of outbreaks of infectious disease. To enhance the identification and control of these threats, ambitious and achievable targets are required.

In response to this need, the World Health Organization (WHO) has developed the Early Action Review (EAR), a performance improvement approach used to evaluate the timeliness of early detection activities and responses to any health event. The EAR, when repeated consistently, establishes the habit of ensuring continual learning and improvement from every event.

EAR is not just an assessment or monitoring tool: it’s a performance management process conducted as early as possible while an event is unfolding. It is used by teams responsible for responding to the event to reinforce the implementation of seven early response actions. These include initiating investigations, conducting epidemiologic analysis, obtaining laboratory confirmation, initiating appropriate case management and infection prevention measures, and establishing a coordination mechanism.


EAR also promotes collaboration and coordination among key stakeholders during the early outbreak response, increasing the likelihood of effective control. When a new outbreak or public health event is identified, stakeholders must coordinate efforts to control the spread of disease and reduce risks or impacts.

The EAR process is designed to find system bottlenecks and fix them quickly. Stakeholders in a response capture data about the timeliness and completion of early response actions as the event unfolds and then identify bottlenecks in the system and enablers of implementation. Documenting these bottlenecks and enablers is critical for prioritising immediate or longer-term remedial actions and identifying best practices.

The WHO has made available five tools to support the conduct of an EAR, which can be downloaded from their website. These tools will be periodically updated, as required. By implementing and improving the EAR process, countries can enhance both their detection speed and response quality, ultimately saving lives and preventing the spread of infectious diseases. 

Reference url

Recent Posts

Cost and clinical impact of MIS-C
      

Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndrome in Children (MIS-C)

🔍 Discovering the Economic Impact of Multisystem Inflammatory Syndrome in Children (MIS-C) 🏥💰

Understanding the cost and clinical impact of MIS-C during COVID-19 is crucial for healthcare providers and policymakers. Learn about treatment costs, patient outcomes, and key statistics related with MIS-C.

🌟#Healthcare #MIS-C #COVID19 #Pediatrics #HealthEconomics #MedicalResearch #HealthcareResearch #MedicalEconomics 📊

Let’s navigate the intersection of healthcare and economics together! 💼 #HealthcareInsights #EconomicAnalysis 🧠

       

Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia

Hepatitis B continues to pose a significant public health challenge, but the World Health Organization continues to work towards achieving their ambition of eliminating HBV as a public health problem by 2030.

One strategy is the Treat All approach, which sounds promising – however, in low-resource settings implementing promising strategies becomes more complex. This study explores striking the balance between promising strategies and getting people the treatment they need.

Learn more about innovative HBV treatment approaches and their impact on global health. Stay informed and join the conversation! 💡🔬 #HealthcareInnovation #HBVResearch

cost effectiveness multiple sclerosis
            

Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis

Exploring the Cost-Utility of MS Treatments: A Comprehensive Review 🧠💼 Dive into the latest findings on the cost-effectiveness of Disease-Modifying Drugs for Multiple Sclerosis. Discover key insights and recommendations for optimizing treatment strategies. #MSresearch #HealthcareEconomics #Neurology #HealthTech 📊🔬

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.